Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

To PCI or not to PCI? Researchers develop predictive tool for stable CAD

Using data from the randomized COURAGE trial, a team of researchers developed a model to predict one-year angina and quality-of-life outcomes among patients with stable coronary artery disease (CAD).

Thumbnail

Researchers explore development of non-invasive therapy to reverse atherosclerosis

Preliminary research presented May 11 at the American Heart Association’s Vascular Discovery: From Genes to Medicine Scientific Sessions 2018, suggests an injection may one day be able to reverse atherosclerosis.

INFINITT Achieves ACC-NCDR Certification for CathPCI® Registry

Phillipsburg, NJ—INFINITT North America, an award-winning developer of image and data management solutions for healthcare, announced today that they have achieved certification from the American College of Cardiology (ACC), demonstrating that INFINITT Cardiology Suite-v. 1.0.8.1 meets NCDR requirements for version 5 of the CathPCI Registry®.

Thumbnail

6-minute walk test predicts cognitive problems after heart surgery

Each 50-meter increase in a six-minute walk test was associated with 20 percent lower odds of developing cognitive dysfunction after cardiac surgery, according to a single-center study from Japan published in The Annals of Thoracic Surgery.

Public reporting of PCI outcomes affects cardiologists’ decision-making

Requiring hospitals and physicians to publicly report their mortality outcomes related to percutaneous coronary intervention (PCI) causes many interventional cardiologists to forego high-risk procedures, researchers reported in JAMA Cardiology.

Thumbnail

PCI outcomes steady at VA hospitals despite older, sicker patients

United States veterans receiving invasive coronary procedures have become older and sicker over the past several years, but adjusted mortality rates for percutaneous coronary intervention (PCI) are in a slight decline.

Thumbnail

Non-acute coronary procedures vary widely by state

New research published in JACC: Cardiovascular Interventions shows substantial variation between states for non-acute coronary angiograms, percutaneous coronary interventions and coronary artery bypass graft surgeries.

Thumbnail

Abbott’s XIENCE Sierra stent to be reimbursed through insurance in Japan

Abbott’s XIENCE Sierra, the newest generation of the company’s everolimus-eluting coronary stent, has been approved for national reimbursement in Japan.

Displaying 937 - 944 of 2683

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.